Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
11 小时
HealthDay on MSNFour Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALSFour immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophi ...
The following is a summary of “Effect of blood alcohol on the diagnostic accuracy of glial fibrillary acidic protein and ...
Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...
Ocrelizumab treatment in Black and Hispanic patients with MS reduces NfL levels and prevents the forming of contrast-enhancing lesions and new or enlarging T2 lesions.
NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options.SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech ...
In line with The Lancet’s 2024 standing Commission showing that 45% of all dementia cases could be prevented by addressing modifiable risk factors, such as physical inactivity and smoking,1 a ...
Dec. 9, 2024 — A new study is helping solve the mystery as to why the brain shrinks in a unique pattern, known as atrophy, in chronic traumatic encephalopathy (CTE). This research provides novel ...
Jan. 30, 2025 — Propranolol, a beta blocker medication used for treating high blood pressure and preventing migraines, may lower ischemic stroke risk in women who experience migraines ..
一些您可能无法访问的结果已被隐去。
显示无法访问的结果